Source:http://linkedlifedata.com/resource/pubmed/id/10568137
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1999-11-30
|
pubmed:abstractText |
Both pheochromocytomas and neuroblastomas can now be identified and located with a high level of accuracy. Scintigraphy with MIBG has become an indispensable diagnostic method for defining the extent and location of many if not most pheochromocytomas. To define the stage, to document the course and to evaluate the response to therapies in patients with neuroblastoma, imaging with MIBG is now essential.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1125-0135
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
217-23
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:10568137-3-Iodobenzylguanidine,
pubmed-meshheading:10568137-Humans,
pubmed-meshheading:10568137-Magnetic Resonance Imaging,
pubmed-meshheading:10568137-Neuroblastoma,
pubmed-meshheading:10568137-Pheochromocytoma,
pubmed-meshheading:10568137-Radiopharmaceuticals,
pubmed-meshheading:10568137-Tomography, X-Ray Computed
|
pubmed:year |
1999
|
pubmed:articleTitle |
Nuclear medicine imaging of pheochromocytoma and neuroblastoma.
|
pubmed:affiliation |
Department of Internal Medicine, University of Michigan Health Systems, Ann Arbor, USA.
|
pubmed:publicationType |
Journal Article,
Review
|